The Mid Canterbury milk processor is the second company to receive a generally recognised as safe (Gras) notice from the US Food and Drug Administration (FDA) to use lactoferrin in those applications.
A Gras notice was added to the FDA register once a food ingredient was scientifically proven to be safe for its intended use.
Lactoferrin is an iron-binding protein recognised for its antibacterial and anti-inflammatory properties. The process took more than six months to complete. In time, it might open up further opportunities for the company, managing director John Penno said.
Investment in a second wet-mix facility is under way to double the infant formula base powder capacity of the company’s Dunsandel site to 80,000 metric tonnes by November.